← Back to the lab

Research group

Spleen & Hemolytic anemia

Led by Camille Roussel

5 members 3 research topics 5 selected publications

About the group

Research focus and expertise

Led by Dr Camille Roussel (Associated Professor, Université Paris Cité-APHP) with a dual appointment at the BioTiGR research unit and the Necker Hospital Hematology Laboratory, our group investigates the spleen's central role in the pathophysiology of hemolytic red blood cell disorders.
Our mission is to bridge fundamental erythrocyte biology with clinical excellence to improve patient care. We focus on constitutional (sickle cell disease, spherocytosis, G6PD deficiency) and acquired hemolytic anemias (AIHA, PNH), with a dedicated goal of identifying and validating new therapeutic options to mitigate hemolysis and its systemic complications.
This work is deeply integrated with our clinical activity at the Necker Hospital Hematology Laboratory. As a Reference Laboratory (LBMR), we specialize in the quantification of pocked cells, a key biomarker of splenic function. By bridging bench research with hospital expertise, we focus on evaluating markers of functionality and their correlation with the clinical complications associated with hyposplenism.

Research topics

01

Spleen Pathophysiology in Hereditary Spherocytosis

Hereditary Spherocytosis is an inherited disorder characterized by rigid, spherical red blood cells (spherocytes) that undergo premature destruction by the spleen. Using an innovative microsphiltration technique that mimics the physical constraints of splenic vvvslits, our group investigates how the spleen contributes to both the elimination and the remodeling (formation) of spherocytes. We are currently exploring whether specific genetic mutations correlate with retention rates in our biomimetic model to better predict clinical disease severity. Ultimately, our research aims to identify novel therapeutic compounds capable of enhancing red blood cell filterability. By employing both targeted candidate and high-throughput screening approaches, we seek to develop medical alternatives that could reduce the need for splenectomy.
This work is supported by l’Agence Nationale de la Recherche et l’American Society of Hematology (Narla and Murthy Family Global Research Award).

02

Protein S and Vaso-Occlusion in Sickle Cell Disease

In Sickle Cell Disease (SCD), abnormal hemoglobin (HbS) causes red blood cell sickling and coagulation activation. In collaboration with Hémostase, inflammation, thrombose (HITh) team (Inserm, Université Paris-Saclay). We explore the non-hemostatic roles of Protein S, focusing on its impact on erythrophagocytosis and endothelial cell adhesion. Our research aims to identify how modulating these pathways could offer new pharmacological targets to prevent vaso-occlusive crises.

03

Hyposplenism: Clinical Markers

The spleen is the only organ responsible for clearing intra-erythrocytic inclusions. A loss of function leads to the persistence of red blood cells containing vacuoles called “pocked cells”. A high proportion of pocked cells is a validated biomarker for hyposplenism, which portends risk life threatening infectious and thrombo-embolic complications. Within the Reference Laboratory (LBMR) at Necker Hospital, we have established routine pocked cell quantification, enabling the assembly of a unique clinical cohort to study the correlation between markers and the long-term complications of hyposplenism, and to Identify and characterize which specific underlying pathologies are major drivers of hyposplenism.

Selected publications

  1. Splenic structural and functional abnormalities in individuals with NR5A1/SF-1 variants

    Khadidja Fouatih, Camille Roussel, Maryse Cartigny, Muriel Houang, Lise Duranteau, Zeina Chakhtoura, Anne-Sophie Lambert, Marie-Agathe Trouvin, Barbara Girerd, Ekaterina Belozertseva, Delphine Borgel, Stephanie Franchi-Abella, Jérôme Bouligand, Maureen Lopez, Kenneth Chappell, Pierre Buffet, Ines Belguith, Claire Bouvattier, Abd El Kader Ait Tayeb

    Endocr Connect, 14, 250549 (2025)

    DOI Link

  2. Protein S Enhances the Phagocytosis of Phosphatidylserine-Exposing Erythrocytes: Implications in Sickle Cell Disease

    Claire Auditeau, Aurélie Fricot, Raphaël Gauthier, Abdoulaye Sissoko, Zeynep Cacan, Céline Gounou, Laure Joseph, Sandra Manceau, Slimane Allali, Michael Dussiot, Mickael Marin, Alexis Lavergne, Mariem Khamari, Sophie Moog, Elsa Bianchini, Laetitia Claer, Sandrine Laurance, Valentine Brousse, Sébastien Eymieux, Philippe Roingeard, Pascal Amireault, Thiago Trovati Maciel, Alain Brisson, Pierre Buffet, François Saller, Delphine Borgel, Camille Roussel

    American Journal of Hematology, 101, 26-40 (2025)

    DOI

  3. Intra-erythrocytic vacuoles in asplenic patients: elusive genesis and original clearance of unique organelles

    Dumas Lucie, Roussel Camille, Buffet Pierre

    Frontiers in physiology, 14, 1324463 (2023)

    DOI Link

  4. Reduced splenic function can mimic artemisinin resistance in severe malaria

    Roussel Camille, Serris Alexandra, Henry Benoît, Lafon Desmurs Barthelemy, Sitterlé Emilie, Bougnoux Marie Elisabeth, Argy Nicolas, Larréché Sébastien, De Montalembert Mariane, Ioos Vincent, Tantaoui Ilhame, Chambrion Charlotte, Fricot Aurélie, Rouzaud Claire, Lanternier Fanny, Lortholary Olivier, Houzé Sandrine, Jauréguiberry Stéphane, Thellier Marc, Ndour Papa Alioune, Buffet Pierre

    Journal of travel medicine, 30, taad144 (2023)

    DOI

  5. Combining imaging flow cytometry and machine learning for high-throughput schistocyte quantification: A SVM classifier development and external validation cohort

    Demagny Julien, Roussel Camille, Le Guyader Maïlys, Guiheneuf Eric, Harrivel Véronique, Boyer Thomas, Diouf Momar, Dussiot Michaël, Demont Yohann, Garçon Loïc

    EBioMedicine, 83, 104209 (2022)

    DOI Link